Forest Laboratories will buy back $350 million of its stock from Morgan Stanley, The Wall Street Journal reports. The maker of antidepressants is looking to complete the buy back by September 30, 2012, adds Forbes.
The company intends to repurchase another $500 million in stock from Morgan Stanley by March 31, 2012. In June, Forest struck a similar deal for $500 million in stock buybacks with the investment bank.
Click here for the story from The Wall Street Journal.
Click here for additional coverage from Forbes.